Rasna Therapeutics Limited was formed in 2013 by a highly experienced industry team together with field-leading scientists, to focus on developing therapeutics to address the high unmet need that exists for AML and other forms of leukemia.

Biotechnology

Rasna Therapeutics

The board of directors at Rasna Therapeutics has experience with various pharmaceutical companies, as well as different types of education. The board consists of a chairman, a CEO, and other members with a variety of backgrounds and experience.

Board of Directors

About

Team members